Atrial Fibrilation Termination Endpoint Clinical Trial
Official title:
Crucial Areas on Atrial Fibrillation Termination by Substrate Ablation: Relevance to Anatomy
| Verified date | March 2014 |
| Source | Hospital St. Joseph, Marseille, France |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
Recent data has demonstrated that focal sources are determinant in human atrial fibrillation
(AF) perpetuation.
The investigators sought to identify crucial areas for AF perpetuation during our routine
electrogram (EGM)-based substrate ablation.
| Status | Completed |
| Enrollment | 113 |
| Est. completion date | March 2014 |
| Est. primary completion date | March 2014 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Atrial Fibrilation - Undergoing EGM-based substrate ablation Exclusion Criteria: - Age < 18 |
| Country | Name | City | State |
|---|---|---|---|
| France | Hopital Saint Joseph | Marseille | |
| France | Hôpital Privé Jacques Cartier; | Massy | |
| France | Institut Mutualiste Montsouris; | Paris | |
| United Kingdom | Morphology Unit Royal Brompton Hospital | London; |
| Lead Sponsor | Collaborator |
|---|---|
| Hospital St. Joseph, Marseille, France |
France, United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Atria fibrillation termination during procedure | conversion to atrial tachycardia (AT) or sinus rhythm | 240 min | |
| Secondary | Crucial points | Crucial points were defined by areas where ablation immediately extended the cycle length> 20% of AF CL, or regularized Atrial Fibrilation (AF) into Atrial Tachycardia (AT) or converted AF (or AT) into Sinus Rythm | 240 min |